Process for the preparation of highly purified antihemophilic factor
US4294826A · kind A · utility
14Cited by
3References
4Claims
0Family size
Assignee
Inventor
Key dates
| Filing date | May 7, 1980 |
| Grant date | Oct 13, 1981 |
| Priority date | — |
| Expiry date | May 7, 2000 |
Classification
- Technology area (CPC Y)Emerging Cross-Sectional Technologies
- CPC primaryY10S530/83
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
An antihemophilic factor derived from human blood plasma, having about 1 to 10 units antihemophilic factor activity per mg of protein and being substantially free of denatured antihemophilic factor is prepared from material having 0.3 to 1.0 unit per mg of protein.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.